SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 436.00
arrow_downward
-0.82%(-3.60) 1D
Sep 24, 5:29:53 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 438.20
High
SEKÂ 439.80
Low
SEKÂ 433.40
Mkt. cap
155.93B
Avg. vol.
268.47K
Volume
356.84K
P/E ratio
116.45
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 262.80
EPS
SEKÂ 3.74
Shares outstanding
357.41M
No. of employees
2K
Open
SEKÂ 438.20
High
SEKÂ 439.80
Low
SEKÂ 433.40
Mkt. cap
155.93B
Avg. vol.
268.47K
Volume
356.84K
P/E ratio
116.45
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 262.80
EPS
SEKÂ 3.74
Shares outstanding
357.41M
No. of employees
2K
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)